Material Agreements

Functional Brands Inc. entered into Notes with Leonite Fund I, LP, Kips Bay Select LP, FirstFire Global Opportunities Fund, LLC and 3i LP valued at $837,800.

“The aggregate consideration paid for the exchange consists of (i) $6,032,160 in stated value of Series C Preferred, (ii) $900,000 in cash, $450,000 payable immediately and $450,000 to be paid upon the earlier of effectiveness of a registration statement covering Common Stock to be issued in connection with a proposed equity line of credit or 90 days after the date of the Exchange Agreement, (iii) $837,800 in principal amount of Notes and (iv) 5,190,171 shares of Common Stock.”

Functional Brands Inc. entered into Exchange Agreement with Leonite Fund I, LP, Kips Bay Select LP, FirstFire Global Opportunities Fund, LLC and 3i LP valued at aggregate assigned stated value of $8,378,000 (effective 2026-03-09).

“Effective as of March 9, 2026, Functional Brands Inc. (the “Company”) entered into the Exchange Agreement with Leonite Fund I, LP, Kips Bay Select LP, FirstFire Global Opportunities Fund, LLC and 3i LP (collectively, the “Investors”) pursuant to which the Investors agreed to exchange all of the Company’s Series A and Series B Convertible Preferred Stock held by such Investors for a combined consideration package consisting of shares of the Company’s new Series C Convertible Preferred Stock (the “Series C Preferred”), cash, Notes and shares of the Company’s common stock , par value $0.00001 per share (the “Common Stock”).”

Apollo Debt Solutions BDC amended Grouse Second Credit Facility Amendment with Goldman Sachs Bank USA (effective 2026-03-12).

“On March 12, 2026 (the “ Second Amendment Date ”), Grouse Funding LLC (“ Grouse Funding ”), a wholly owned subsidiary of Apollo Debt Solutions BDC, a Delaware statutory trust (the “ Company ”) entered into the Second Amendment (the “ Grouse Second Credit Facility Amendment ”) to its Credit Agreement (the “ Grouse Secured Credit Facility ”), dated as of July 7, 2022, by and among Grouse Funding, as borrower, the Company, as investment manager and as guarantor, the lenders from time to time party thereto, Goldman Sachs Bank USA, as syndication agent and administrative agent, State Street Bank and Trust Company, as collateral custodian and collateral agent, and Virtus Group, LP, as collateral administrator.”

Profusa, Inc. terminated Account Control Agreement with Ascent Partners Fund LLC (effective 2026-03-12).

“On March 12, 2026, Ascent Partners Fund LLC (the “Secured Party”) notified the Company of the termination of the Account Control Agreement (the “Control Agreement”), dated as of September 29, 2025, among the Company, as pledgor, the Secured Party, BitGo Prime LLC (the “Delegate”), and BitGo Trust Company, Inc. (the “Custodian”).”

MultiSensor AI Holdings, Inc. amended Amendment with certain investors (effective 2026-03-12).

“on March 12, 2026, the Company and certain investors party to that certain Securities Purchase Agreement, dated October 24, 2025 (as amended, the “Securities Purchase Agreement”), entered into an amendment to the Securities Purchase Agreement (the “Amendment”) to permit the Offering.”

MultiSensor AI Holdings, Inc. entered into Sales Agreement with Roth Capital Partners, LLC and H.C. Wainwright & Co., LLC valued at up to $60,000,000 (effective 2026-03-13).

“On March 13, 2026, MultiSensor AI Holdings, Inc., a Delaware corporation (the “Company”) entered into an at market issuance sales agreement (the “Sales Agreement”) with Roth Capital Partners, LLC and H.C. Wainwright & Co., LLC, as sales agents or principals (the “Agents”), under which the Company may offer and sell shares of the Company’s common stock, par value $0.0001 per share, having an aggregate market value of up to $60,000,000 from time to time through the Agents (the “Offering”).”

1606 CORP. entered into Purchase and Sale Agreement with Jefferson Enterprise Energy, LLC valued at $11,168,864 (effective 2026-03-12).

“On March 12, 2026, 1606 Corp., a Nevada corporation (the " Company "), entered into a Purchase and Sale Agreement (the " Agreement ") with Jefferson Enterprise Energy, LLC, a Texas limited liability company (" Seller "), pursuant to which the Company agreed to purchase certain real property located in Angelina County, Texas, including land, improvements, equipment, permits, warranties and related documents (collectively, the " Property "). The total purchase price for the Property is $11,168,864, consisting of (i) $7,000,000 in cash payable at closing and (ii) the Company's assumption of a mechanic's and materialman's lien recorded as Instrument No. 2025-00458298 in the Official Public Records of Angelina County, Texas (the " Sim Agro Lien ").”

Silvaco Group, Inc. entered into Open Market Sale Agreement with Jefferies LLC valued at up to $15.0 million (effective 2026-03-13).

“On March 13, 2026, Silvaco Group, Inc. (the “Company”) entered into an Open Market Sale Agreement SM (the “Sales Agreement”) with Jefferies LLC, as sales agent (the “Sales Agent”), pursuant to which the Company may offer and sell from time to time, at its option through the Sales Agent, shares of the Company’s common stock, $0.0001 par value per share, having an aggregate offering price of up to $15.0 million”

Venture Global, Inc. amended Project Facilities with not explicitly named valued at $20.7 billion under the Project Facilities (effective 2026-03-13).

“On March 13, 2026, Venture Global CP2 LNG, LLC (“CP2”), an indirect, wholly-owned subsidiary of Venture Global, Inc. (the “Company”), amended or amended and restated, as applicable, certain of its financing documents, by upsizing (i) the $11.25 billion senior secured first lien construction term loan facility (the “Phase 1 Construction/Term Facility”) by an aggregate amount equal to $7.85 billion (the “Phase 2 Construction/Term Facility”) and (ii) the $850.0 million senior secured first lien working capital revolving loan and letter of credit facility (the “Working Capital Facility” and, together with the Phase 1 Construction/Term Facility and the Phase 2 Construction/Term Facility, the “Project Facilities”) by $750.0 million, resulting in an aggregate amount of $20.7 billion under the Project Facilities”

AGL Private Credit Income Fund entered into Amended and Restated Limited Liability Company Agreement for AGL Enhanced PC Income I LLC with Vintage Strategies at Goldman Sachs Alternatives valued at Up to $300 million aggregate investment ($75 million from Company, $225 million from Vintage Strateg (effective 2026-03-09).

“On March 9, 2026, AGL Private Credit Income Fund (the “Company”) and certain vehicles managed by Vintage Strategies at Goldman Sachs Alternatives (“Vintage Strategies”) entered into an amended and restated limited liability company agreement for AGL EPCI I (the “LLC Agreement”), an unconsolidated entity.”

Calumet, Inc. /DE entered into Tenth Amendment to the Third Amended and Restated Credit Agreement with the lenders party thereto and Bank of America, N.A., as administrative agent (effective 2026-03-12).

“On March 12, 2026, the Company entered into the Tenth Amendment to the Third Amended and Restated Credit Agreement (the “Tenth Amendment”), which modifies the Third Amended and Restated Credit Agreement, dated as of February 23, 2018, by and among the General Partner, the Partnership, certain of the Company’s subsidiaries party thereto, the lenders party thereto and Bank of America, N.A., as administrative agent, to permit the issuance of, and the incurrence of indebtedness in connection with, the Additional Notes.”

Calumet, Inc. /DE entered into Purchase Agreement with BofA Securities, Inc. as representative of the several initial purchasers valued at $150.0 million (effective 2026-03-12).

“On March 12, 2026, Calumet Specialty Products Partners, L.P. (the “Partnership”), Calumet Finance Corp. (“Finance Corp.” and, together with the Partnership, the “Issuers”), Calumet, Inc. (the “Company”), Calumet GP, LLC (the “General Partner”) and certain subsidiary guarantors named therein (the “Subsidiary Guarantors”) entered into a purchase agreement (the “Purchase Agreement”) with BofA Securities, Inc. as representative of the several initial purchasers named therein (collectively, the “Initial Purchasers”), under which they agreed to sell $150.0 million aggregate principal amount of the Issuers’ 9.75% Senior Notes due 2031 (the “Additional Notes”) in a private placement conducted pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended.”

Karman Holdings Inc. amended Fourth Amendment with Citibank, N.A., as Administrative Agent and Collateral Agent valued at $100,000,000 (effective 2026-03-09).

“On March 9, 2026, Karman Holdings Inc. (the “Company”) entered into a Fourth Amendment to its Credit Agreement (the “Fourth Amendment"), which amends the Credit Agreement, dated as of April 1, 2025”

AVIS BUDGET GROUP, INC. entered into Series 2026-2 Supplement with The Bank of New York Mellon Trust Company, N.A. (effective 2026-03-11).

“the Series 2026-2 Supplement, dated as of the Closing Date, between ABRCF and The Bank of New York Mellon Trust Company, N.A., as trustee and Series 2026-2 Agent (the “Series 2026-2 Supplement”)”

AVIS BUDGET GROUP, INC. entered into Series 2026-1 Supplement with The Bank of New York Mellon Trust Company, N.A. (effective 2026-03-11).

“the Series 2026-1 Supplement, dated as of the Closing Date, between ABRCF and The Bank of New York Mellon Trust Company, N.A., as trustee and Series 2026-1 Agent (the “Series 2026-1 Supplement”)”

CLEARONE INC terminated Warrant Repurchase Agreement with CVI Investments, Inc. valued at aggregate purchase price of $22,000 (effective 2026-03-09).

“On March 9, 2026, ClearOne, Inc. (the “Company”) entered into a Warrant Repurchase Agreement (the “Agreement”) with CVI Investments, Inc. (“CVI”), pursuant to which the Company repurchased certain outstanding common stock purchase warrants previously issued to CVI.”

LITTELFUSE INC /DE entered into "Credit Agreement" with each of the banks, financial institutions and other institutional lenders listed on the respective signature pages thereof valued at $800 million senior unsecured revolving credit facility (effective 2026-03-12).

“On March 12, 2026, Littelfuse, Inc., a Delaware corporation (the “Company”), entered into the Credit Agreement as described below. The Credit Agreement provides for an $800 million senior unsecured revolving credit facility”

PARKERVISION INC entered into Exchange Agreement with Holders valued at aggregate outstanding principal amount of $675,000 and accrued and unpaid interest of approximately (effective 2026-03-13).

“On March 13, 2026, ParkerVision, Inc., a Florida corporation (the “ Company ”) entered into exchange agreements (each an "Exchange Agreement" and collectively, the "Exchange Agreements") with certain holders (the "Holders") of the Company's outstanding convertible promissory notes (the "Exchange Notes").”

UNIVERSAL ELECTRONICS INC amended Twelfth Amendment with U.S. Bank National Association (effective 2026-03-11).

“On March 11, 2026, Universal Electronics Inc. (“UEI” or the “Company”) entered into a Twelfth Amendment (the “Twelfth Amendment” to the Second Amended and Restated Credit Agreement, dated as of October 27, 2017 (as amended, “Credit Agreement”), with the lender thereto and U.S. Bank National Association, as administrative agent.”

Salesforce, Inc. entered into Five-Year Credit Agreement with the lenders named th (effective 2026-03-11).

“Five-Year Credit Agreement On March 11, 2026, the Company entered into a Five-Year Credit Agreement with the lenders named th”

Salesforce, Inc. entered into Underwriting Agreement with J.P. Morgan Securities LLC, BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc. and Wells Fargo Securities, LLC valued at $3,500,000,000 aggregate principal amount of 4.500% Senior Notes due 2028 (the “2028 Notes”), $4,250 (effective 2026-03-11).

“On March 11, 2026, Salesforce entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc. and Wells Fargo Securities, LLC, on behalf of the several Underwriters listed in Schedule A thereto (the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters $3,500,000,000 aggregate principal amount of 4.500% Senior Notes due 2028 (the “2028 Notes”), $4,250,000,000 aggregate principal amount of 4.650% Senior Notes due 2029 (the “2029 Notes”), $3,750,000,000 aggregate principal amount of 4.900% Senior Notes due 2031 (the “2031 Notes”), $2,750,000,000 aggregate principal amount of 5.200% Senior Notes due 2033 (the “2033 Notes”), $4,500,000,000 aggregate principal amount of 5.550% Senior Notes due 2036 (the “2036 Notes”), $1,500,000,000 aggregate principal amount of 6.400% Senior Notes due 2046 (the “2046 Notes”), $3,750,000,000 aggregate princ”

Salesforce, Inc. entered into ASR Agreements with Banco Santander, S.A., Bank of America, N.A., Citibank, N.A., JPMorgan Chase Bank, National Association, and Morgan Stanley & Co. LLC valued at $25 billion (effective 2026-03-11).

“On March 11, 2026, Salesforce, Inc. (the “Company” or “Salesforce”) entered into accelerated share repurchase agreements (the “ASR Agreements”) with Banco Santander, S.A., Bank of America, N.A., Citibank, N.A., JPMorgan Chase Bank, National Association, and Morgan Stanley & Co. LLC (collectively, the “ASR Counterparties”). Under the terms of the ASR Agreements, the Company will repurchase an aggregate of $25 billion of the Company’s common stock”

Integer Holdings Corp entered into Cooperation Agreement with Irenic Capital Management LP, Irenic Capital Management GP LLC, Irenic Capital Evergreen Master Fund LP, and Irenic Capital Evergreen Fund GP LLC (collectively, the "Irenic Parties") (effective 2026-03-09).

“On March 9, 2026 (the “Effective Date”), Integer Holdings Corporation (the “Company”) entered into a Cooperation Agreement (the “Cooperation Agreement”) by and among the Company, Irenic Capital Management LP, a Delaware limited partnership, Irenic Capital Management GP LLC, a Delaware limited liability company, Irenic Capital Evergreen Master Fund LP, a Cayman Islands limited partnership, and Irenic Capital Evergreen Fund GP LLC, a Delaware limited liability company (together, the “Irenic Parties”).”

GLOBAL PAYMENTS INC entered into Supplemental Indenture No. 8 with U.S. Bank Trust Company, National Association valued at $500 million aggregate principal amount of 4.550% Senior Notes due 2028 and $500 million aggregate p (effective 2026-03-12).

“On March 12, 2026, Global Payments Inc. (the “Company”) completed the previously announced public offering (the “Offering”) and issuance of: · $500 million aggregate principal amount of its 4.550% Senior Notes due 2028 (the “2028 Notes”); and · $500 million aggregate principal amount of its 5.400% Senior Notes due 2033 (the “2033 Notes,” and together with the 2028 Notes, the “Notes”).”

APPLIED OPTOELECTRONICS, INC. amended Amendment No. 1 to the Equity Distribution Agreement with Raymond James & Associates, Inc. and Needham & Company, LLC valued at $500 million (effective 2026-03-12).

“On March 12, 2026, Applied Optoelectronics, Inc. (the “Company”) entered into Amendment No. 1 to the Equity Distribution Agreement (the “Amendment”) with Raymond James & Associates, Inc. and Needham & Company, LLC (collectively, the “Sales Agents”), amending the Equity Distribution Agreement dated as of February 26, 2026 among the Company and the Sales Agents (the “Original Agreement” and, together with the Amendment, the “Agreement”).”

IIOT-OXYS, Inc. entered into Securities Purchase Agreement with GHS Investments, LLC valued at up to $88,000 (effective 2026-03-06).

“On March 6, 2026, IIOT-OXYS, Inc., a Nevada corporation (the “ Company ”), entered into a Securities Purchase Agreement (the “ SPA ”) with GHS Investments, LLC (“ GHS ”) for the purchase and sale of up to ninety-seven (97) shares of the Company’s Series D Convertible Preferred Stock (the “ Preferred Stock ”) for an aggregate purchase price of up to $88,000.”

ITC Holdings Corp. entered into ITCMW Bond Purchase Agreement with initial bondholders named in Schedule A valued at $175,000,000 (effective 2026-03-12).

“ITCMW Series O Bonds and the ITCMW Series P Bonds were sold to institutional accredited investors (as defined by Rule 501(a) of the Securities Act) pursuant to a Bond Purchase Agreement, dated March 12, 2026, between ITCMW and the initial bondholders named in Schedule A thereto (the “ITCMW Bond Purchase Agreement”)”

ITC Holdings Corp. entered into ITCT Bond Purchase Agreement with initial bondholders named in Schedule A valued at $175,000,000 (effective 2026-03-12).

“ITCT Series M Bonds and the ITCT Series N Bonds were sold to institutional accredited investors (as defined by Rule 501(a) of the Securities Act) pursuant to a Bond Purchase Agreement, dated March 12, 2026, between ITC Transmission and the initial bondholders named in Schedule A thereto (the “ITCT Bond Purchase Agreement”)”

IGC Pharma, Inc. entered into a credit facility with One Deck Capital, Inc. valued at approximately $219,000.

“The Company entered into a loan agreement with One Deck Capital, Inc. (“One Deck”), pursuant to which the Company received approximately $219,000 in financing (the “One Deck Loan”).”

IGC Pharma, Inc. entered into Promissory Note with Vanquish Funding Group Inc. valued at $353,050 (effective 2026-03-05).

“Pursuant to the terms of the Purchase Agreement, the Company issued a Promissory Note (the “Note”) to VFG with a total principal amount of $353,050”

IGC Pharma, Inc. entered into Securities Purchase Agreement with Vanquish Funding Group Inc. (effective 2026-03-05).

“On March 5, 2026, IGC Pharma, Inc. (“IGC” or the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Vanquish Funding Group Inc., a Virginia corporation (“VFG” or the “Holder”).”

BCP Investment Corp amended Third Amendment with Great Lakes Portman Ridge Funding LLC valued at $125,000,000 (effective 2026-03-09).

“On March 9, 2026, Great Lakes Portman Ridge Funding LLC (“SPV”), a wholly-owned subsidiary of BCP Investment Corporation (the “Company”), entered into a third amendment (the “Third Amendment”) to its senior secured revolving credit facility dated December 18, 2019”

Quest Resource Holding Corp terminated Loan, Security and Guaranty Agreement with PNC Bank, National Association (effective 2026-03-12).

“On March 12, 2026, contemporaneously with the execution and delivery of the TCB Loan Agreement, that certain Loan, Security and Guaranty Agreement, dated as of August 5, 2020, as amended, with PNC Bank, National Association, successor to BBVA USA, as a lender, and as administrative agent, collateral agent, and issuing bank, was terminated in accordance with its terms thereof and all outstanding amounts thereunder were repaid.”

Quest Resource Holding Corp entered into TCB Loan Agreement with Texas Capital Bank valued at $40.0 million (effective 2026-03-12).

“On March 12, 2026, the Company and certain of its domestic subsidiaries entered into a Loan and Security Agreement with Texas Capital Bank (the “TCB Loan Agreement”).”

Quest Resource Holding Corp amended Amendment to Warrant to Purchase Common Stock with Holders (affiliates of Monroe) (effective 2026-03-12).

“On March 12, 2026, the Company and the Holders entered into an Amendment to Warrant to Purchase Common Stock to each of the Warrants to extend the expiration date of the Warrants from March 19, 2028 to June 28, 2030.”

Quest Resource Holding Corp amended Monroe Eighth Amendment with Monroe Capital Management Advisors, LLC (effective 2026-03-12).

“On March 12, 2026, Quest Resource Holding Corporation (the “Company”) and certain of its domestic subsidiaries entered into an amendment (the “Monroe Eighth Amendment”) to that certain Credit Agreement, dated as of October 19, 2020”

NGL Energy Partners LP amended Seventh Amendment to Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent, and the financial institutions party thereto as lenders (effective 2026-03-12).

“On March 12, 2026, Partnership entered into that certain Seventh Amendment to Credit Agreement (the “ABL Amendment”), by and among Operating LLC, as borrower, Partnership, certain of Partnership’s direct and indirect wholly owned subsidiaries, as guarantors, JPMorgan Chase Bank, N.A., as administrative agent, and the financial institutions party thereto as lenders, which amends the terms of Partnership’s existing asset-based revolving credit facility (the “ABL Facility”).”

NGL Energy Partners LP entered into Term Loan Credit Agreement with Barclays Bank PLC, as administrative agent and collateral agent, and the lenders party thereto valued at $950.0 million (effective 2026-03-12).

“On March 12, 2026, NGL Energy Partners LP (“Partnership”) entered into a new term loan credit agreement, dated March 12, 2026 (the “Term Loan Credit Agreement”), by and among Partnership, NGL Energy Operating LLC (“Operating LLC”), a wholly owned subsidiary of Partnership, as borrower, Barclays Bank PLC, as administrative agent and collateral agent, and the lenders party thereto, which provides for a $950.0 million term loan (the “Term Loan”).”

Esquire Financial Holdings, Inc. entered into Agreement and Plan of Merger with Signature Bancorporation, Inc. (effective 2026-03-11).

“On March 11, 2026, Esquire Financial Holdings, Inc., a Maryland corporation (“Esquire”), Esquire Merger Sub, Inc., a Maryland corporation and a direct, wholly owned subsidiary of Esquire (“Merger Sub”), and Signature Bancorporation, Inc., an Illinois corporation (“Signature”), entered into an Agreement and Plan of Merger (the “Merger Agreement”).”

Diamondback Energy, Inc. entered into Underwriting Agreement with SGF FANG Holdings, LP and Evercore Group L.L.C., Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters (effective 2026-03-10).

“On March 10, 2026, Diamondback Energy, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with SGF FANG Holdings, LP (the “ Selling Stockholder ”) and Evercore Group L.L.C., Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein”

CACI INTERNATIONAL INC /DE/ entered into Second Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $500 million aggregate principal amount (effective 2026-03-12).

“On March 12, 2026, CACI International Inc (“CACI”), the subsidiary guarantors named therein (the “Guarantors”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), entered into a second supplemental indenture (the “Second Supplemental Indenture”) to the indenture, dated as of June 2, 2025 (the “Base Indenture”), as supplemented by that first supplemental indenture (the “First Supplemental Indenture”), dated as of November 25, 2025 (the Base Indenture, as supplemented by the First Supplemental Indenture and the Second Supplemental Indenture, the “Indenture”), pursuant to which CACI issued (the “Offering”) $500 million aggregate principal amount of CACI’s unsecured Senior Notes due 2033 (the “Additional Notes”)”

Virtuix Holdings Inc. amended Warrant Amendments with Streeterville Capital, LLC valued at Reduced exercise price period extended for 90 days; exercise price $6.00 per warrant share (effective 2026-03-11).

“On March 11, 2026, Virtuix Holdings Inc. (the "Company") entered into amendments to each of the following warrants to purchase shares of Class A Common Stock (collectively, the "Warrant Amendments") with Streeterville Capital, LLC (the "Investor") extending the Reduced Exercise Price Period (as defined below) to each such warrant”

Senseonics Holdings, Inc. entered into Local Asset Purchase Agreements with Ascensia Diabetes Care Holdings AG valued at Cash payment of respective Net Book Value (effective 2026-03-12).

“On March 12, 2026, the Purchaser Parties and the Seller Parties entered into the Local Purchase Agreements, pursuant to which, among other things, the Purchaser Parties agreed to acquire Seller’s and as applicable, Seller Parties’, right, title and interest in and to the European Purchased Assets and to assume the European Assumed Liabilities, as contemplated by the Master Asset Purchase Agreement.”

Kezar Life Sciences, Inc. entered into Asset Purchase Agreement with Enodia Therapeutics SAS valued at $800,000 in cash at the closing and will receive an additional $200,000 on the earlier to occur of ( (effective 2026-03-06).

“On March 6, 2026, Kezar Life Sciences, Inc. (the “Company”) and Enodia Therapeutics SAS, a French simplified joint stock company (“Enodia”), entered into an asset purchase agreement (the “Agreement”) pursuant to which Enodia (i) acquired all of the Company’s rights, title and interest in the Company’s Sec61-based discovery and development program assets, including the product candidate internally known as KZR-261 (collectively, the “Assets”); and (ii) assumed liabilities from the Company related to certain transferred contracts and from the ownership, use, operation or maintenance of the Assets under the Agreement (the “Transaction”).”

Laird Superfood, Inc. entered into Registration Rights Agreement with Nexus.

““ Nexus Investment ” and, together with the Navitas Acquisition, the “ Transactions ”). A substantial portion of the proceeds from the Nexus Investment were used to complete the Navitas Acquisition.”

Dianthus Therapeutics, Inc. /DE/ entered into Underwriting Agreement with Jefferies LLC, TD Securities (USA) LLC, Evercore Group L.L.C., Stifel, Nicolaus & Company, Incorporated and Guggenheim Securities, LLC, as the representatives of the underwriters valued at approximately $673.5 million (effective 2026-03-10).

“On March 10, 2026, Dianthus Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (“Underwriting Agreement”) with Jefferies LLC, TD Securities (USA) LLC, Evercore Group L.L.C., Stifel, Nicolaus & Company, Incorporated and Guggenheim Securities, LLC, as the representatives of the underwriters named therein (the “Underwriters”), to issue and sell 7,313,582 shares of the Company’s common stock at a public offering price of $81.00 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 402,468 shares of the Company’s common stock (the “Pre-Funded Warrants”) at a public offering price of $80.999 per share, which represents the per share public offering price for the common stock less the $0.001 per share exercise price for each Pre-Funded Warrant (the “Offering”).”

T Stamp Inc entered into Consulting Agreement with CyberFish valued at Fees of £65,000 per year (effective 2026-03-09).

“Also on March 9, 2026, Trust Stamp Malta Limited entered into a Consulting Agreement (the “ Consulting Agreement ”) with CyberFish.”

T Stamp Inc entered into Shareholders Agreement with CyberFish and Berta Pappenheim valued at Not disclosed (effective 2026-03-09).

“Also on the March 9, 2026, in connection with the closing of the SPA, and to govern the parties’ ongoing relationship as shareholders of CyberFish, Trust Stamp Malta Limited entered into a Shareholders Agreement (the “ Shareholders Agreement ”) with (i) Berta Pappenheim and (ii) CyberFish.”

T Stamp Inc entered into Share Purchase Agreement with CyberFish CyberPsychology Solutions Ltd valued at Total Consideration of £190,000 (effective 2026-03-09).

“On March 9, 2026, Trust Stamp Malta Limited, a wholly-owned subsidiary of T Stamp Inc. (the “ Company ”), entered into a Share Purchase Agreement (the “ SPA ”) with CyberFish CyberPsychology Solutions Ltd, a private company incorporated in England and Wales (“ CyberFish ”).”

Longeveron Inc. entered into Purchase Agreement with certain institutional and accredited investors (effective 2026-03-10).

“On March 10, 2026, Longeveron Inc., a Delaware corporation (the “Company”), entered into a Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (each, an “Investor” and collectively, the “Investors”), pursuant to which the Company agreed to issue and sell shares of the Company’s Class A common stock, par value $0.001 per share (the “Common Stock”) and, shares of the Company’s Series A Non-Voting Convertible Preferred Stock, par value $0.001 per share, and stated value of $1,000 per share (the “Series A Preferred Stock,” and together with the Common Stock, the “Securities”) to the Investors in up to two closings in a private placement (the “Private Placement”).”